Actively Recruiting
Exploring Enlonstobart Combined With Chemotherapy and Radiotherapy After Induction Therapy in Women With Locally Advanced Cervical Cancer
Led by Tianjin Medical University Cancer Institute and Hospital · Updated on 2026-08-25
31
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to assess the efficacy and safety of Enlonstobart combined with chemoradiotherapy after induction chemotherapy in patients with locally advanced cervical cancer. It focuses on whether this combination can improve the objective response rate and disease control rate, while monitoring for any serious adverse effects. The study is sponsored by Tianjin Medical University Cancer Institute and Hospital and involves patients with cervical squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma at FIGO stage III-IV A who have not received prior treatment. Participants will first receive induction therapy with Enlonstobart combined with chemotherapy agents such as paclitaxel and platinum. This is followed by Enlonstobart administered alongside concurrent radiotherapy, including external beam radiation and brachytherapy, plus chemotherapy. The treatment aims to evaluate the combined regimens effects and safety. The study is a single-group, Phase 4 interventional trial with no placebo or comparison group. During the study, participants will undergo regular tumor imaging tests like CT or MRI scans and hematological safety assessments. Researchers will collect data on treatment efficacy, document adverse events, and conduct long-term follow-up, assessing outcomes up to three years. Key measurements include objective response rate, progression-free survival, disease control rate, and overall survival. The total participation period extends through treatment and follow-up until study completion.
CONDITIONS
Brief Title
An Exploratory Study on the Efficacy and Safety of Enlonstobart Combined With Concurrent Radiotherapy and Chemotherapy Following Induction Therapy With Enlonstobart Plus Chemotherapy in Patients With Locally Advanced Cervical Cancer.
Research Team
L
Liming Xu Liming Xu
Y
Yaomei Ma
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here